Back to search
FDAFDA · Food and drugs·Recall number D-0327-2026

Testosterone 75mg, Anastrozole 4mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4079-32.

Published February 18, 2026 · Recall initiated: January 26, 2026

Summary

FDA records drug Class II recall D-0327-2026, published February 18, 2026 and initiated January 26, 2026. Recalling firm: F.H. INVESTMENTS, Inc. (dba Asteria Health); Status: Ongoing; Reported quantity: 670 pellets; Lot: Lot#: 254000107, Exp. 06/30/2026; 254000111, Exp. 08/07/2026. . Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign substance - potential presence of metal particulate matter

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Distributor
Nationwide in the USA
Lot
Lot#: 254000107, Exp. 06/30/2026; 254000111, Exp. 08/07/2026. .
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Testosterone 75mg, Anastrozole 4mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4079-32. recalled?

Yes. FDA published recall D-0327-2026 on February 18, 2026. Reported hazard: Presence of Foreign substance - potential presence of metal particulate matter

What should I do if I have this product?

Voluntary: Firm initiated · Letter